Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial.
By D. Galvão, D. Taaffe, N. Spry, D. Joseph, Robert Usher Newton. Journal of Clinical Oncology, 2010
620 citations recorded by the source corpus.
Subfields: Oncology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/40af687d45459ec679489bdf695f05ceebd98d13
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. (2010, background): “Of the 12 intervention studies, 6 specifically reported on safety (lack of harm in comparison to control participants) of exercise interventions in this population (20,43,45,58,96,119).”
- Nutrition and physical activity guidelines for cancer survivors (2012, background): “An increasing number of studies have examined the therapeutic value of exercise during primary cancer treatment.(26,27) Existing evidence strongly suggests that exercise CA CANCER J CLIN 2012;62:242-274”
- Adverse effects of androgen deprivation therapy and strategies to mitigate them. (2015, background): “[88] 57 Reduced fatigue compared with usual care”
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. (2020, background): “3) for up to 3 mo in men treated with ADT [181].”
- Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations (2020, background): “Numerous studies have demonstrated the therapeutic benefits of exercise during primary anticancer treatment.(183,184) It is recommended during anticancer treatment, but can also improve physical functioning, fatigue and quality of life (QoL).”